Cargando…
Redirection to the bone marrow improves T cell persistence and antitumor functions
A key predictor for the success of gene-modified T cell therapies for cancer is the persistence of transferred cells in the patient. The propensity of less differentiated memory T cells to expand and survive efficiently has therefore made them attractive candidates for clinical application. We hypot...
Autores principales: | Khan, Anjum B., Carpenter, Ben, Santos e Sousa, Pedro, Pospori, Constandina, Khorshed, Reema, Griffin, James, Velica, Pedro, Zech, Mathias, Ghorashian, Sara, Forrest, Calum, Thomas, Sharyn, Gonzalez Anton, Sara, Ahmadi, Maryam, Holler, Angelika, Flutter, Barry, Ramirez-Ortiz, Zaida, Means, Terry K., Bennett, Clare L., Stauss, Hans, Morris, Emma, Lo Celso, Cristina, Chakraverty, Ronjon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919805/ https://www.ncbi.nlm.nih.gov/pubmed/29485974 http://dx.doi.org/10.1172/JCI97454 |
Ejemplares similares
-
CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor
por: Ghorashian, Sara, et al.
Publicado: (2015) -
Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo
por: Xue, Shao-An, et al.
Publicado: (2013) -
Heterogeneous run-and-tumble motion accounts for transient non-Gaussian super-diffusion in haematopoietic multi-potent progenitor cells
por: Partridge, Benjamin, et al.
Publicado: (2022) -
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
por: Alsaieedi, Ahdab, et al.
Publicado: (2018) -
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
por: Nicholson, Emma, et al.
Publicado: (2012)